We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Illumina, Inc.

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

Single-cell transcriptomics has revolutionized the study of cellular diversity and function by enabling gene expression ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

The Global Synthetic Biology Market is estimated to be valued at USD 13.83 billion in 2023 and is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 17.30% over the forecast period ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

The import ban on Illumina's NGS sequencers follows its placement on China's Ministry of Commerce's (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock.

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger surrogate polymers, and he cofounded sequencing company Stratos Genomics back in ...

Illumina has been barred from exporting its DNA sequencers to China ... the reagents or consumables necessary to run the sequencing machines. “Illumina will continue to serve our customers ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

uhn.ca The purpose of this document is to provide guidance for the use of next-generation sequencing ... by synthesis)—a sequencing method based on the identification of single bases as they are ...